JACC This Week
By American College of Cardiology
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by American College of Cardiology
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 107
Reviews: 0
Episodes: 729
Description
A weekly co-hosted podcast featuring JACC Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC and JACC Senior Consulting Editor Carolyn S.P. Lam, MBBS, PhD, giving readers context on our weekly issues. Listen in as they break down the latest trends and share practical tips that are changing the way heart care works globally.
| Episode | Date |
|---|---|
|
March 31, 2026: Global Cardiovascular Insights & Breakthroughs from China | JACC This Week
|
Mar 31, 2026 |
|
March 24, 2026: Cardiometabolic Health, COVID Impact & Prevention Science | JACC This Week
|
Mar 24, 2026 |
|
March 17, 2026: Heart Failure, Chagas Research & AI in Cardiology | JACC This Week
|
Mar 17, 2026 |
|
March 10, 2026: Inside JACC Stats: The State of CV Health in Focus | JACC this Week
|
Mar 10, 2026 |
|
March 3, 2026: Hypertrophic Cardiomyopathy in Focus—MAPLE-HCM Trial, Myosin Inhibitors & What Improvement Really Means | JACC This Week
|
Mar 03, 2026 |
|
February 24, 2026: ACHD Guideline in Focus—From Survival to Stewardship | JACC This Week
|
Feb 24, 2026 |
|
February 17, 2026: Women's Cardiovascular Health in Focus: From Inclusion to Redesign | JACC This Week
|
Feb 17, 2026 |
|
JACC This Week Bonus Episode – Women's Cardiovascular Health: From Inclusion to Redesign
|
Feb 17, 2026 |
|
February 10, 2026: Amyloidosis in Focus: Diagnosis Delays, Early Treatment, and What Clinicians Must Know | JACC This Week
|
Feb 10, 2026 |
|
February 3, 2026: A New Season of JACC This Week: Valve Disease, Editorial Vision, and Engaging the Global Cardiology Community | JACC This Week
|
Feb 03, 2026 |
|
December 2, 2025: Global CVD 1990–2023: Trends, Risks, and the Road Ahead | JACC This Week
|
Nov 24, 2025 |
|
November 25, 2025: Clonal Hematopoiesis, Alcohol and Blood Pressure, Long-Term Risk, and Emerging Biomarkers | JACC This Week
|
Nov 17, 2025 |
|
November 18, 2025: Adiposity, Heart Failure, and the Future of Cardiometabolic Care | JACC This Week
|
Nov 10, 2025 |
|
November 11, 2025: Precision, Place, and the Future of Cardiovascular Prediction | JACC This Week
|
Nov 03, 2025 |
|
November 4, 2025: The 2025 Hypertension Guideline: A New Era in Blood Pressure Control | JACC This Week
|
Oct 28, 2025 |
|
October 28.2025: How Low Should We Go? | JACC This Week
|
Oct 20, 2025 |
|
October 21, 2025 - The Adipokine Hypothesis, Adipose-Cardiac Signaling, Sex Differences, Therapeutic Implications, and Diverse Populations | JACC This Week
|
Oct 13, 2025 |
|
October 14, 2025 - Emerging Frontiers in Cardiovascular Medicine: From Certification Reform to Inflammation Targeting | JACC This Week
|
Oct 06, 2025 |
|
October 7, 2025: AI in Scientific Writing and New Frontiers in Cardiovascular Care | JACC This Week
|
Sep 29, 2025 |
|
Computable Quality, Community Screening, and TAVR Debate | JACC This Week
|
Sep 29, 2025 |
|
AI, Polygenic Risk Scores, and Antithrombotic Therapy | JACC This Week
|
Sep 15, 2025 |
|
Reframing Cardiovascular Care | JACC This Week
|
Sep 08, 2025 |
|
Heart Failure Insights, AI Standards, and Genetic Clues | JACC This Week
|
Sep 03, 2025 |
|
Cognitive Risk in CHD and Cardiology Practice Meets Lifestyle Realities | JACC This Week
|
Aug 25, 2025 |
|
Pacing Strategies, Air Quality, and the Path to Equity | JACC This Week
|
Aug 18, 2025 |
|
Device Safety, DAPT Strategy & Structural Innovation | JACC This Week
|
Aug 11, 2025 |
|
Amyloidosis in Focus: Biomarkers, Structural Insights & Therapeutic Strategy | JACC This Week
|
Aug 04, 2025 |
|
Out-of-Hospital Cardiac Arrest in Septuagenarians, Octogenarians, and Nonagenarians in Japan: Trends and Patterns in Outcomes | JACC Baran
|
Jul 29, 2025 |
|
Zeroing In on Prevention: ARIC and the Future of Cardiovascular Risk | JACC Baran
|
Jul 29, 2025 |
|
Epidemiology and Outcomes in HFimpEF | JACC Deep Dive
|
Jul 28, 2025 |
|
Heart Failure in Practice: Dual Therapy Insights, Digital Innovation & the Future of Risk Models | JACC This Week
|
Jul 28, 2025 |
|
JACC Editor's Page: June 30, 2025 | JACC
|
Jul 21, 2025 |
|
JACC Editor's Page: July 7. 2025 | JACC
|
Jul 21, 2025 |
|
IHCA Incidence Rates | JACC Deep Dive
|
Jul 21, 2025 |
|
Plaque Vulnerability and Risk Factors | JACC Deep Dive
|
Jul 21, 2025 |
|
Validation of AHA PREVENT in Healthcare Populations | JACC Deep Dive
|
Jul 21, 2025 |
|
ACURATE neo2 Under-Expansion | JACC Deep Dive
|
Jul 21, 2025 |
|
Structural Heart Disease, Obesity-Related Heart Failure, Private Equity Ownership in Hospitals | JACC This Week
|
Jul 21, 2025 |
|
Prevention in Focus: Polypill Projections, Risk Equations & Global Syndemic Trends | JACC This Week
|
Jul 14, 2025 |
|
Cardiovascular Interventions in Focus: Plaque Vulnerability, PCI Outcomes & Outpatient Cardiac Care Trends | JACC This Week
|
Jul 07, 2025 |
|
Electrophysiology in Focus: AFIB Management, LAA Closure Insights and Stroke Risk Strategies | JACC This Week
|
Jun 30, 2025 |
|
Podcasts at JACC: Past and Future | JACC This Week
|
Jun 23, 2025 |
|
JACC Editor's Page: June 23, 2025 | JACC
|
Jun 23, 2025 |
|
Wildfire-Linked Heart Failure, Impella Trial Insights, Cognitive Impairment in CVD & New Mortality Data | JACC This Week
|
Jun 23, 2025 |
|
JACC Editor's Page: June 16, 2025
|
Jun 17, 2025 |
|
Long-term Survival and Patient Reported Outcomes after Staged Reconstructive Surgery for Hypoplastic Left Heart Syndrome | JACC
|
Jun 16, 2025 |
|
Relationship between exercise-induced cardiac troponin elevations and occult coronary atherosclerosis in middle-aged athletes | JACC
|
Jun 16, 2025 |
|
Differences in Arterial Events in Ehlers-Danlos, Loeys-Dietz, and Marfan Syndrome | JACC
|
Jun 16, 2025 |
|
Characterization of Arterial Aneurysms in Loeys-Dietz Syndrome | JACC
|
Jun 16, 2025 |
|
June 24, 2025 Issue Summary | JACC
|
Jun 16, 2025 |
|
Sleep and Heart Failure: LV Function Findings from the ADVENT-HF Trial | JACC Baran
|
Jun 10, 2025 |
|
JACC Editor's Page: June 9, 2025
|
Jun 09, 2025 |
|
Long-acting Factor XI Inhibition and Peri-procedural Bleeding: An Analysis from AZALEA-TIMI 71 | JACC
|
Jun 09, 2025 |
|
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of an International Multicenter Prospective Registry | JACC
|
Jun 09, 2025 |
|
Predicting Heart Failure Outcomes Using Patient-Reported Health Status: Real-World Validation of the KCCQ-12 | JACC
|
Jun 09, 2025 |
|
10-Year and 30-Year Risks of Cardiovascular Disease in the U.S. Population | JACC
|
Jun 09, 2025 |
|
June 17, 2025 Issue Summary | JACC
|
Jun 09, 2025 |
|
ACS Guidelines | A Latin American Perspective | JACC
|
Jun 03, 2025 |
|
ACS Guidelines | Closer to a Universal Document | JACC
|
Jun 03, 2025 |
|
ACS Guidelines | Maturation of Lipid Management | JACC
|
Jun 03, 2025 |
|
ACS Guidelines | A Holistic View | JACC
|
Jun 03, 2025 |
|
ACS Guidelines | Gaps Within Evidence Gaps | JACC
|
Jun 03, 2025 |
|
ACS Guidelines | A Personal Perspective | JACC
|
Jun 03, 2025 |
|
ACS Guidelines | MCS in Acute Myocardial Infarction-Cardiogenic Shock | JACC
|
Jun 03, 2025 |
|
Chronic Stent Recoil: A Hidden Cost of Thinner Struts? | JACC Baran
|
Jun 03, 2025 |
|
June 10, 2025 Issue Summary | JACC
|
Jun 02, 2025 |
|
Acoramidis and Early sTTR Rise: Biomarker-Driven Insights into Survival | JACC Baran
|
May 27, 2025 |
|
June 3, 2025 Issue Summary | JACC
|
May 27, 2025 |
|
Insights From the INTERASPIRE Study | JACC Deep Dive
|
May 27, 2025 |
|
SORT OUT XI | EuroPCR.25 | JACC
|
May 21, 2025 |
|
VT Prevention in Repaired Tetralogy of Fallot: Mapping SCAI and Minimizing ICDs | JACC Baran
|
May 20, 2025 |
|
Vutrisiran Impact on Functional Capacity and QOL | JACC Deep Dive | JACC
|
May 20, 2025 |
|
10 Year Outcome of DANAMI 3 PRIMULTI | JACC | EuroPCR.25 | JACC
|
May 19, 2025 |
|
May 27, 2025 Issue Summary | JACC
|
May 19, 2025 |
|
Vutrisiran and Mortality in ATTR-CM | JACC | ESCHF25
|
May 17, 2025 |
|
Rethinking Rehab: ACTIVE-ADHF and the Power of Early Intervention | JACC Baran
|
May 13, 2025 |
|
Individual Variation in Tirzepatide Response | JACC Deep Dive
|
May 13, 2025 |
|
JACC Editor's Page: March 18, 2025 | JACC
|
May 12, 2025 |
|
May 20, 2025 Issue Summary | JACC
|
May 12, 2025 |
|
Altshock-2 Through a Regional Lens: IABP in HF-CS | JACC Baran
|
May 06, 2025 |
|
Revisiting the SUMMIT Trial | JACC Deep Dive
|
May 06, 2025 |
|
Disentangling the Impact of Adiposity From Insulin Resistance in HFpEF | JACC Deep Dive
|
May 06, 2025 |
|
Anthracycline Cardiotoxicity in Adult Cancer Patients: JACC: CardioOncology State-of-the-Art Review | JACC
|
May 05, 2025 |
|
Disentangling the Impact of Adiposity From Insulin Resistance in Heart Failure with Preserved Ejection Fraction | JACC
|
May 05, 2025 |
|
Effect of Empagliflozin on the Mechanisms Driving Erythropoiesis and Iron Mobilization in Patients With Heart Failure: the EMPEROR Program | JACC
|
May 05, 2025 |
|
Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction and Obesity: the SUMMIT Trial | JACC
|
May 05, 2025 |
|
May 13, 2025 Issue Summary | JACC
|
May 05, 2025 |
|
Ischemia on Dobutamine Stress Echocardiography Predicts Efficacy of PCI: Results from ORBITA-2 | JACC
|
May 05, 2025 |
|
JACC Editor's Page: May 13, 2025
|
May 05, 2025 |
|
Aortic Stenosis Under Pressure: Decoding Low-Gradient Risk Profiles | JACC Baran
|
Apr 29, 2025 |
|
1-Year Results of ADVANTAGE AF | JACC Deep Dive
|
Apr 29, 2025 |
|
Sudden Cardiac Arrest in Young Athletes | JACC Deep Dive
|
Apr 29, 2025 |
|
JACC Editor's Page: May 6, 2025 | JACC
|
Apr 28, 2025 |
|
State of the Art: Mapping Strategies to Guide Ablation in Ischemic Heart Disease | JACC
|
Apr 28, 2025 |
|
Proactive mapping and preventive ablation reduce defibrillator implantation rates in Tetralogy of Fallot | JACC
|
Apr 28, 2025 |
|
Survival Outcomes after Sudden Cardiac Arrest in Young Competitive Athletes from the United States | JACC
|
Apr 28, 2025 |
|
Pulse Field Ablation for Persistent Atrial Fibrillation: One-Year Results of ADVANTAGE AF | JACC
|
Apr 28, 2025 |
|
Finerenone Reduces New-Onset Atrial Fibrillation across the Spectrum of Cardio-Kidney-Metabolism: the FINE-HEART Pooled Analysis | JACC
|
Apr 28, 2025 |
|
Advancing Electrophysiology: Innovations, Challenges, and the Future of Arrhythmia Management | JACC
|
Apr 28, 2025 |
|
May 6, 2025 Issue Summary | JACC
|
Apr 28, 2025 |
|
Bridging Gaps for SCD Prevention in HCM: Why Regional Validation Matters | JACC Baran
|
Apr 22, 2025 |
|
Altshock-2 | JACC Deep Dive
|
Apr 21, 2025 |
|
JACC Editor's Page: April 29, 2025 | JACC
|
Apr 21, 2025 |
|
Mixed Cardiogenic-Vasodilatory Shock: Current Insights and Future Directions | JACC
|
Apr 21, 2025 |
|
A Vascular Plug for Persistent Shock Following Transcatheter Mitral Valve Replacement | JACC
|
Apr 21, 2025 |
|
LAVA-ECMO–Supported Dual-Transcatheter Aortic and Mitral Valve-in-Valve Replacement in Cardiogenic Shock | JACC
|
Apr 21, 2025 |
|
Nonhemorrhagic Pericardial Effusion With Tamponade and Cardiogenic Shock Due to Large Coronary Artery Fistula | JACC
|
Apr 21, 2025 |
|
Single-Access Technique for Impella-Assisted Balloon Aortic Valvuloplasty and High-Risk PCI in Cardiogenic Shock | JACC
|
Apr 21, 2025 |
|
The Influence of Extracorporeal Life Support on Patients in Cardiogenic Shock Assessed by Machine Learning: A Machine Learning Subanalysis From the ECLS-SHOCK Trial | JACC
|
Apr 21, 2025 |
|
2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Evaluation and Management of Cardiogenic Shock | JACC
|
Apr 21, 2025 |
|
Early Intra-Aortic Balloon Support for Heart Failure-Related Cardiogenic Shock: A Randomized Clinical Trial | JACC
|
Apr 21, 2025 |
|
Advancing Care in Cardiogenic Shock: Evidence, Innovation, and Commitment | JACC
|
Apr 21, 2025 |
|
April 29, 2025 Issue Summary | JACC
|
Apr 21, 2025 |
|
From Hokkaido to ACC: NT-proBNP Screening for Pre-Heart Failure in Rural Japan | JACC Baran
|
Apr 15, 2025 |
|
JACC Editor's Page: April 22, 2025 | JACC
|
Apr 14, 2025 |
|
Conduction Disturbances After Transcatheter Aortic Valve Replacement: An Update on Epidemiology, Preventive Strategies, and Management | JACC
|
Apr 14, 2025 |
|
Impact of Catheter Ablation of Atrial Fibrillation on Disease Progression | JACC
|
Apr 14, 2025 |
|
Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry | JACC
|
Apr 14, 2025 |
|
Pre-Pregnancy Adiposity, Adverse Pregnancy Outcomes, and Cardiovascular Disease Risk in Midlife | JACC
|
Apr 14, 2025 |
|
5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis | JACC
|
Apr 14, 2025 |
|
April 22, 2025 Issue Summary | JACC
|
Apr 14, 2025 |
|
Troponin in Translation: The 0/1-Hour Algorithm Across Asia | JACC Baran
|
Apr 08, 2025 |
|
JACC Editor's Page: April 15, 2025 | JACC
|
Apr 07, 2025 |
|
Genetic Risk and First-Trimester Cardiovascular Health Predict Hypertensive Disorders of Pregnancy in Nulliparous Individuals | JACC
|
Apr 07, 2025 |
|
Cardiac Troponins and Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis | JACC
|
Apr 07, 2025 |
|
April 15, 2025 Issue Summary | JACC
|
Apr 07, 2025 |
|
Small Molecule PCSK9 Inhibitor for Hypercholesterolemia | JACC | ACC.25
|
Apr 01, 2025 |
|
Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies | JACC | ACC.25
|
Apr 01, 2025 |
|
Early Intra-Aortic Balloon Support for Heart Failure-Related Cardiogenic Shock | JACC | ACC.25
|
Apr 01, 2025 |
|
Individual Variation in Tirzepatide Response | JACC | ACC.25
|
Apr 01, 2025 |
|
Survival After Sudden Cardiac Arrest in Athletes | JACC | ACC.25
|
Apr 01, 2025 |
|
Self-Expanding Valve Outcomes at 5 Years Compared to Surgery | JACC | ACC.25
|
Apr 01, 2025 |
|
Gold Cards & Hidden Triggers: A New Look at Afib | JACC Baran
|
Apr 01, 2025 |
|
The Cardiovascular Care of the Pediatric Athlete | JACC
|
Mar 31, 2025 |
|
Impact of Transcather or Surgical Aortic Valve Performance on 5-Year Outcomes in Patients at ≥Intermediate Risk | JACC
|
Mar 31, 2025 |
|
Nonlinear Relation between Cardiac Mortality and Excess Temperature in Heatwaves: Exposure Response in 2.39 Million Patients | JACC
|
Mar 31, 2025 |
|
New Threshold for Defining Mild Aortic Stenosis Derived from Velocity-Encoded MRI in 60,000 Individuals | JACC
|
Mar 31, 2025 |
|
April 8, 2025 Issue Summary | JACC
|
Mar 31, 2025 |
|
Incident Atrial Fibrillation in FINE-HEART | JACC | ACC.25
|
Mar 27, 2025 |
|
Use of Cardiac Rehab in Older Patients with MI Complicated by Cardiogenic Shock | JACC | ACC.25
|
Mar 25, 2025 |
|
Effect of plozasiran on lipoprotein particles by NMR | JACC | ACC.25
|
Mar 25, 2025 |
|
Exploring High-Gradient Aortic Stenosis | JACC Baran
|
Mar 25, 2025 |
|
Vutrisiran Efficacy by Baseline ATTR-CM Severity | JACC | ACC.25
|
Mar 24, 2025 |
|
Elevated remnant cholesterol contributes to the risk of peripheral artery disease: a Mendelian randomization study | JACC
|
Mar 24, 2025 |
|
Invasive versus Conservative Management of Patients with Chronic Total Occlusion: Results From the ISCHEMIA Trial | JACC
|
Mar 24, 2025 |
|
Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial | JACC
|
Mar 24, 2025 |
|
Ensemble Deep Learning Algorithm for Structural Heart Disease Screening Using Electrocardiographic Images: PRESENT SHD | JACC
|
Mar 24, 2025 |
|
Bioprosthetic vs Mechanical Aortic Valve Replacement in Patients 40-75 Years | JACC
|
Mar 24, 2025 |
|
April 1, 2025 Issue Summary | JACC
|
Mar 24, 2025 |
|
Use of Cardiac Rehab in Older Patients with MI Complicated by Cardiogenic Shock | JACC | ACC.25
|
Mar 24, 2025 |
|
Federal Funding Cuts & Aortic Valve Replacement Outcomes | JACC Baran
|
Mar 18, 2025 |
|
A New Era in Electrophysiology: Innovation, Integration, and Impact | JACC
|
Mar 17, 2025 |
|
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-analysis of Randomized Trials | JACC
|
Mar 17, 2025 |
|
In the Wake of OCEANIC-AF is Factor XI inhibition Lost at Sea or Still Afloat? | JACC
|
Mar 17, 2025 |
|
In CASTLE-HTx Trial We Trust | JACC
|
Mar 17, 2025 |
|
Biomarker-based model for prediction of ischemic stroke in patients with atrial fibrillation | JACC
|
Mar 17, 2025 |
|
Antithrombotic Therapy to Minimize Total Events after ACS or PCI in Atrial Fibrillation: Insights from AUGUSTUS | JACC
|
Mar 17, 2025 |
|
Five-Year Results from the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | JACC
|
Mar 17, 2025 |
|
Can ICD Electrograms help Ventricular Tachycardia Ablation? Results From the Multicenter Randomized AIDEG-VTA Trial | JACC
|
Mar 17, 2025 |
|
Worldwide Chronic Retrieval Experience of Helix-Fixation Leadless Cardiac Pacemakers | JACC
|
Mar 17, 2025 |
|
March 25, 2025 Issue Summary | JACC
|
Mar 17, 2025 |
|
JACC Editor's Page: March 25, 2025 | JACC
|
Mar 17, 2025 |
|
Systolic BP & CV Mortality in US Adults Aged 80+ Taking Antihypertensive Medications| JACC | ACC.25
|
Mar 17, 2025 |
|
RSV and Incidence of Cardiovascular Events | JACC | ACC.25 | JACC
|
Mar 17, 2025 |
|
Cognitive Function and Patient-Reported Outcomes after Cardiogenic Shock | JACC | ACC.25
|
Mar 17, 2025 |
|
Managing Cardiogenic Shock Caused by Acute MI | JACC | ACC.25
|
Mar 17, 2025 |
|
Skype and Diaphragm Ultrasound in Heart Failure | JACC Baran
|
Mar 11, 2025 |
|
JACC Editor's Page: March 18, 2025 | JACC
|
Mar 10, 2025 |
|
Clinical Considerations for Q1 Competitive Sports Participation for Athletes With Cardiovascular Abnormalities | JACC
|
Mar 10, 2025 |
|
Best Practices for Imaging of Transcatheter Valve Failure: An Update from the Heart Valve Collaboratory | JACC
|
Mar 10, 2025 |
|
Association between cigarette smoking and subclinical markers of cardiovascular harm | JACC
|
Mar 10, 2025 |
|
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy | JACC
|
Mar 10, 2025 |
|
Clinical Effect of Genetic Testing in Inherited Cardiovascular Diseases : A 14-Year Retrospective Study | JACC
|
Mar 10, 2025 |
|
Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients with Heart Failure | JACC
|
Mar 10, 2025 |
|
March 18, 2025 Issue Summary | JACC
|
Mar 10, 2025 |
|
Diagnostic Performance and Clinical Impact of Photon-Counting Detector CT in CAD | JACC Baran
|
Mar 04, 2025 |
|
Advancing Transcatheter Aortic Valve Replacement: Expanding Evidence, Refining Strategies | JACC: Inside This Issue
|
Mar 03, 2025 |
|
Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis: JACC State-of-the-Art Review | JACC
|
Mar 03, 2025 |
|
Transcatheter vs Surgical Aortic Valve Replacement in Lower-Risk Patients: An Updated Meta-Analysis of Randomized Controlled Trials | JACC
|
Mar 03, 2025 |
|
Aortic Valve Replacement vs Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis | JACC
|
Mar 03, 2025 |
|
Predictors of Outcomes of Reintervention After Transcatheter Aortic Valve Replacement: FRANCE 2 and FRANCE TAVI Registries | JACC
|
Mar 03, 2025 |
|
Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD | JACC
|
Mar 03, 2025 |
|
The Evolving Landscape of TAVR: A JACC Themed Issue | JACC
|
Mar 03, 2025 |
|
March 11, 2025 Issue Summary | JACC
|
Mar 03, 2025 |
|
P2Y12 Inhibitor Pretreatment in Non–ST-Segment Elevation Acute Coronary Syndrome: The NCDR Chest Pain-MI Registry | JACC Baran
|
Feb 25, 2025 |
|
The Essential Role of Cardiovascular Surgery in Cardiology - JACC
|
Feb 24, 2025 |
|
Domino Heart Valve Transplant in Children With Congenital Valve Disease: Short-Term Outcomes, Growth, and Immunosensitization | JACC
|
Feb 24, 2025 |
|
Outcomes for Children With Congenital Heart Disease Undergoing Ventricular Assist Device Implantation: An ACTION Registry Analysis | JACC
|
Feb 24, 2025 |
|
Long-Term Outcomes of Contemporary Surgical Repair for Degenerative Mitral Regurgitation | JACC
|
Feb 24, 2025 |
|
The Effect of Teleprehabilitation on Adverse Events After Elective Cardiac Surgery: A Randomized Controlled Trial | JACC
|
Feb 24, 2025 |
|
Days Alive Out of Health Care: A Novel Measure of Health Status After Congenital Heart Surgery | JACC
|
Feb 24, 2025 |
|
The Nonsyndromic Ascending Thoracic Aorta in a Population-Based Setting: A 5-Year Prospective Cohort Study | JACC
|
Feb 24, 2025 |
|
The Essential Role of Cardiovascular Surgery in Cardiology: A Perspective From JACC | JACC
|
Feb 24, 2025 |
|
Introducing JACC-Baran & FINEARTS-HF Renal Function | JACC Baran
|
Feb 18, 2025 |
|
The Super Bowl & HCM Proteomics | JACC Baran
|
Feb 18, 2025 |
|
Standardized Definitions of Changes in Kidney Function in Trials of Heart Failure: JACC Expert Panel From the HF-ARC
|
Feb 17, 2025 |
|
JACC - Preprints: A Revolution in Cardiovascular Science
|
Feb 10, 2025 |
|
2024 ACC Expert Consensus Decision Pathway on Practical Approaches for Arrhythmia Monitoring After Stroke: A Report of the American College of Cardiology Solution Set Oversight Committee
|
Feb 10, 2025 |
|
Management of Coronary Stent Underexpansion
|
Feb 10, 2025 |
|
Associations of Short-Term Ozone Exposure With Hypoxia and Arterial Stiffness
|
Feb 10, 2025 |
|
Treating Older Patients in Cardiogenic Shock With a Microaxial Flow Pump: Is it DANGERous?
|
Feb 10, 2025 |
|
Myocardial Fibroblast Activation After Acute Myocardial Infarction: A Positron Emission Tomography and Magnetic Resonance Study
|
Feb 10, 2025 |
|
Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs Second-Generation DES: TARGET-IV NA Trial
|
Feb 10, 2025 |
|
JACC - February 18, 2025 Issue Summary
|
Feb 10, 2025 |
|
Navigating the 2024 ESC Hypertension Guidelines: What Is New, Context, and Future Directions
|
Feb 03, 2025 |
|
Intraindividual Variability in Serial Lipoprotein(a) Concentrations Among Placebo-Treated Patients in the OCEAN(a)-DOSE Trial
|
Feb 03, 2025 |
|
Incidental and Progressive Tobacco Smoking in Childhood and Subsequent Risk of Premature Cardiac Damage
|
Feb 03, 2025 |
|
Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity
|
Feb 03, 2025 |
|
Real-World Efficacy and Safety of Inclisiran: A Single-Country, Multicenter, Observational Study (CHOLINET Registry)
|
Feb 03, 2025 |
|
Social Determinants of Health, Cardiovascular Health, and Mortality in Sexual Minority Individuals in the United States
|
Feb 03, 2025 |
|
Long-Term Lipid Lowering With Evolocumab in Older Individuals
|
Feb 03, 2025 |
|
Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary Study
|
Feb 03, 2025 |
|
Accelerometer-Measured Sedentary Behavior and Risk of Future Cardiovascular Disease
|
Feb 03, 2025 |
|
Higher Aircraft Noise Exposure Is Linked to Worse Heart Structure and Function by Cardiovascular MRI
|
Feb 03, 2025 |
|
Secondary Prevention Medications in 17 Countries Grouped by Income Level (PURE): A Prospective Cohort Study
|
Feb 03, 2025 |
|
Advancing Prevention: Insights From JACC's Focus Issue
|
Feb 03, 2025 |
|
JACC - Transforming Publishing: Your Paper, Your Way at JACC
|
Jan 28, 2025 |
|
Contributors and Solutions to High Out-of-Pocket Costs for Heart Failure Medications: A State-of-the-Art Review
|
Jan 27, 2025 |
|
2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis
|
Jan 27, 2025 |
|
The Association of Hospital-Cardiologist Integration with Patient Outcomes, Care Quality, and Utilization
|
Jan 27, 2025 |
|
Diagnostic Performance and Clinical Impact of Photon-Counting Detector Computed Tomography in Coronary Artery Disease
|
Jan 27, 2025 |
|
P2Y12 Inhibitor Pretreatment in Non-ST Elevation Acute Coronary Syndrome: The NCDR Chest Pain-MI Registry
|
Jan 27, 2025 |
|
A Contemporary Picture of Coagulase-negative Staphylococcal Endocarditis: A Nationwide GAMES Cohort Study
|
Jan 27, 2025 |
|
JACC - February 4, 2025 Issue Summary
|
Jan 27, 2025 |
|
Advances in Transcatheter Tricuspid Valve Interventions: Implications for Health Policy
|
Jan 20, 2025 |
|
Transcatheter Interventions in Tricuspid Regurgitation: Shifting the Focus Beyond Quantity of Life to Quality of Life
|
Jan 20, 2025 |
|
Amara Yad Image: The Tricuspid Valve
|
Jan 20, 2025 |
|
The Amara Yad Project: A New Resource for Cardiac Anatomy
|
Jan 20, 2025 |
|
Transcatheter Tricuspid Valve Replacement
|
Jan 20, 2025 |
|
Advanced Imaging Assessment of the Impact of Tricuspid Regurgitation on Cardiac Remodeling: The TRILUMINATE Pivotal Imaging Substudy
|
Jan 20, 2025 |
|
Tricuspid Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: 1-Year Outcomes From the TRILUMINATE Randomized Cohort
|
Jan 20, 2025 |
|
Transcatheter Valve Repair for Tricuspid Regurgitation: 1-Year Results From a Large European Real-World Registry
|
Jan 20, 2025 |
|
Quality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal Trial
|
Jan 20, 2025 |
|
Tricuspid Valve Interventions: A New Era in Cardiovascular Innovation
|
Jan 20, 2025 |
|
Did Finerenone Improve Health Status in the FINEARTS Trial?: A Critical Reevaluation of the Analysis of Patient-Reported Outcomes in Heart Failure
|
Jan 13, 2025 |
|
Initial Decline In Glomerular Filtration Rate With Finerenone In Hfmref/Hfpef: a Prespecified Analysis of Finearts-Hf
|
Jan 13, 2025 |
|
Finerenone And Kidney Outcomes In Patients With Heart Failure: the Finearts-Hf Trial
|
Jan 13, 2025 |
|
Finerenone, Obesity, And Heart Failure With Mildly Reduced/Preserved Ejection Fraction: a Prespecified Analysis of Finearts-Hf
|
Jan 13, 2025 |
|
Effect of Finerenone On the Kccq In Patients With Hfmref/Hfpef: a Prespecified Analysis of Finearts-Hf
|
Jan 13, 2025 |
|
Use of Finerenone For Heart Failure And Intermediate Or Preserved Ejection Fraction: the Finearts-Hf Trial
|
Jan 13, 2025 |
|
A Comprehensive Exploration of FINEARTS-HF: A JACC Theme Issue
|
Jan 13, 2025 |
|
JACC - Obesity as a Disease | JACC
|
Jan 09, 2025 |
|
JACC - The Terminology of Obesity | JACC
|
Jan 09, 2025 |
|
JACC - Obesity Medication Usage | JACC
|
Jan 09, 2025 |
|
JACC - Obesity Medication Concerns | JACC
|
Jan 09, 2025 |
|
JACC - Shame and Blame | JACC
|
Jan 09, 2025 |
|
JACC - Is There Healthy Obesity? | JACC
|
Jan 09, 2025 |
|
JACC - The Cardiologist's Role in Treating Obesity | JACC
|
Jan 09, 2025 |
|
JACC - Should Cardiologists Care About Obesity? | JACC
|
Jan 09, 2025 |
|
Effect of valve type and anesthesia strategy for TAVR – 5-year results of the SOLVE-TAVI trial
|
Jan 06, 2025 |
|
Association of Systemic Thromboxane Generation with Risk of Developing Heart Failure
|
Jan 06, 2025 |
|
Machine Learning-based Prediction of Death and Hospitalization in Patients with Implantable Cardioverter Defibrillators
|
Jan 06, 2025 |
|
Optimal Strategy for Complete Revascularization in ST-Elevation Myocardial Infarction and Multivessel Disease: A Network Meta-Analysis
|
Jan 06, 2025 |
|
Drug-Coated Balloon Angioplasty Of the Side Branch During Provisional Stenting: The Multicenter Randomized DCB-BIF Trial
|
Jan 06, 2025 |
|
JACC - January 7 - 14, 2025 Issue Summary
|
Jan 06, 2025 |
|
Anatomic and Physiologic Repair of Congenitally Corrected Transposition of the Great Arteries
|
Dec 09, 2024 |
|
Excess Mortality and Hospitalizations Associated with Seasonal Influenza in Patients with Heart Failure
|
Dec 09, 2024 |
|
Impact of Renal & Liver Function on Clinical Outcomes Following Tricuspid Valve Transcatheter Edge-to-Edge Repair
|
Dec 09, 2024 |
|
Oxidized Phospholipids and Calcific Aortic Valvular Disease
|
Dec 09, 2024 |
|
Cardiac MRI Predictors of Arrhythmic Sudden Cardiac Events in Patients with Fontan Circulation
|
Dec 09, 2024 |
|
JACC - December 17 - 24, 2024 Issue Summary
|
Dec 09, 2024 |
|
Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared with Placebo for Initial Treatment of Hypertension
|
Dec 02, 2024 |
|
Aspirin Monotherapy versus No Antiplatelet Therapy in Stable Patients with Coronary Stents Undergoing Low-to-Intermediate Risk Non-cardiac Surgery
|
Dec 02, 2024 |
|
Percutaneous Transcatheter Edge-to-Edge Repair for Functional Mitral Regurgitation in Heart Failure: A Meta-analysis of Randomized Controlled Trials
|
Dec 02, 2024 |
|
Hospitalizations in Symptomatic Patients with Heart Failure and Moderate to Severe Functional Mitral Regurgitation: Insights from RESHAPE-HF2
|
Dec 02, 2024 |
|
Major Bleeding and Mortality After Revascularization of Left Main Disease
|
Dec 02, 2024 |
|
JACC - December 10, 2024 Issue Summary
|
Dec 02, 2024 |
|
Sudden Death in Obesity: Mechanisms and Management
|
Nov 25, 2024 |
|
Length of Hospital Stay for Endocarditis. Before and After Partial Oral Treatment of Endocarditis Trial
|
Nov 25, 2024 |
|
Artificial Intelligence-Enhanced Electrocardiogram Diastolic Function Assessment for Prognostic Stratification in Mitral Regurgitation
|
Nov 25, 2024 |
|
Hypertensive disorders of pregnancy increase risk for myocardial infarction: a population-based study
|
Nov 25, 2024 |
|
Two-Fold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis: A Nationwide Registry Study
|
Nov 25, 2024 |
|
JACC - December 3, 2024 Issue Summary
|
Nov 25, 2024 |
|
Systolic Blood Pressure and Pulse Pressure in Heart Failure: Pooled Participant-Level Analysis of Four Trials
|
Nov 21, 2024 |
|
JACC - SUMMIT 2024: A Video Interview with Harlan Krumholz and Milton Packer| JACC | AHA 2024
|
Nov 20, 2024 |
|
JACC - Recap of AHA From Harlan Krumholz, Editor-in-Chief
|
Nov 20, 2024 |
|
JACC - Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients with Heart Failure
|
Nov 20, 2024 |
|
JACC - Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity
|
Nov 20, 2024 |
|
JACC - Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy
|
Nov 20, 2024 |
|
JACC - Outpatient Worsening Heart Failure in Patients with ATTR CM in the HELIOS-B Trial | JACC | AHA 2024
|
Nov 20, 2024 |
|
JACC - Five-Year Results from the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial
|
Nov 20, 2024 |
|
JACC - Intensive lifestyle intervention, cardiac biomarkers, and cardiovascular outcomes in diabetes: LookAHEAD cardiac biomarker ancillary study
|
Nov 20, 2024 |
|
JACC - DanGer Shock trial: The impact of age | JACC | AHA 2024
|
Nov 20, 2024 |
|
JACC - Oxidized Phospholipids and Calcific Aortic Valvular Disease
|
Nov 20, 2024 |
|
JACC - Accelerometer-Measured Sedentary Behavior & Risk of Future Cardiovascular Disease | JACC | AHA 2024
|
Nov 20, 2024 |
|
JACC - P2Y12 Inhibitor Pretreatment in Non-ST Elevation Acute Coronary Syndrome: The NCDR Chest Pain-MI Registry
|
Nov 20, 2024 |
|
JACC - Hospital-Cardiologist Integration and Outcomes | JACC | AHA 2024
|
Nov 20, 2024 |
|
JACC - Rural-Urban Differences in Cardiovascular Mortality in the United States, 2010-2022
|
Nov 20, 2024 |
|
Consequences of Discontinuation of Long-Term Treatment in Patients With Heart Failure and Reduced Ejection Fraction
|
Nov 18, 2024 |
|
Clinical implications of Pre-test probability of HFpEF on Outcomes in Precapillary Pulmonary Hypertension
|
Nov 18, 2024 |
|
ApoA-I Infusions and Burden of Ischemic Events after Acute Myocardial Infarction
|
Nov 18, 2024 |
|
Prevalence and Impact of Recurrent Rejection on Pediatric Heart Transplant Recipients: A PHTS Multi-Institutional Analysis
|
Nov 18, 2024 |
|
Associations of Self-reported Race, Polygenic Risk, and Social Determinants of Health with Coronary Heart Disease
|
Nov 18, 2024 |
|
JACC - November 26, 2024 Issue Summary
|
Nov 18, 2024 |
|
JACC Journals at AHA | JACC | AHA 2024
|
Nov 13, 2024 |
|
Ten Years of Leadless Cardiac Pacing
|
Nov 11, 2024 |
|
Embryological Classification of Arrhythmogenic Triggers Initiating Atrial Fibrillation
|
Nov 11, 2024 |
|
Intraoperative Conduction Mapping to Reduce Postoperative Atrioventricular Block in Complex Congenital Heart Disease
|
Nov 11, 2024 |
|
Non-Modifiable Risk Factors Predict Outcomes in Brugada Syndrome
|
Nov 11, 2024 |
|
Screening for Undiagnosed Atrial Fibrillation and Stroke Prevention
|
Nov 11, 2024 |
|
JACC - November 19, 2024 Issue Summary
|
Nov 11, 2024 |
|
Artificial Intelligence in Cardiovascular Clinical Trials
|
Nov 04, 2024 |
|
Recaticimab as add-on therapy to statins for non-familial hypercholesterolaemia: the phase 3 REMAIN-2 trial
|
Nov 04, 2024 |
|
Recaticimab Monotherapy for Non-Familial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized Trial
|
Nov 04, 2024 |
|
Complete vs. Culprit-Only Revascularization in Older Patients with Myocardial Infarction with or without ST-segment elevation
|
Nov 04, 2024 |
|
Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy
|
Nov 04, 2024 |
|
Reaffirmation of Mechanistic Proteomic Signatures Accompanying SGLT2 Inhibition in Heart Failure: a EMPEROR Validation Cohort
|
Nov 04, 2024 |
|
JACC - November 12, 2024 Issue Summary
|
Nov 04, 2024 |
|
Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs. Second-Generation DES: TARGET-IV NA Trial
|
Oct 30, 2024 |
|
Quality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal Trial
|
Oct 30, 2024 |
|
Drug-Coated Balloon Angioplasty Of the Side Branch During Provisional Stenting: The Multicenter Randomized DCB-BIF Trial
|
Oct 28, 2024 |
|
Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD
|
Oct 28, 2024 |
|
Family Screening in Hypertrophic Cardiomyopathy - Identification of Relatives with Low Yield from Systematic Follow-up
|
Oct 28, 2024 |
|
Standard of Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM
|
Oct 28, 2024 |
|
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM
|
Oct 28, 2024 |
|
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy
|
Oct 28, 2024 |
|
Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM CMR Substudy
|
Oct 28, 2024 |
|
Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM
|
Oct 28, 2024 |
|
JACC - November 5, 2024 Issue Summary
|
Oct 28, 2024 |
|
Transcatheter Valve Repair for Tricuspid Regurgitation: 1-Year Results From a Large European Real-World Registry
|
Oct 27, 2024 |
|
Tricuspid Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: 1-year Outcomes From the TRILUMINATE Randomized Cohort
|
Oct 27, 2024 |
|
Aspirin Hypersensitivity in Patients with Atherosclerotic Cardiovascular Disease
|
Oct 21, 2024 |
|
AI-Facilitated Assessment of Built Environment Using Neighborhood Satellite Imagery and Cardiovascular Risk
|
Oct 21, 2024 |
|
FcγRIIa: A Marker of Cardiovascular Risk after Myocardial Infarction
|
Oct 21, 2024 |
|
The IRONMAN trial of intravenous iron for heart failure. Adjudication of hospitalizations and deaths.
|
Oct 21, 2024 |
|
Asymptomatic versus symptomatic hypotension with sacubitril/valsartan in heart failure and reduced ejection fraction in PARADIGM-HF
|
Oct 21, 2024 |
|
JACC - October 29, 2024 Issue Summary
|
Oct 21, 2024 |
|
Inflammation in Obesity-Related HFpEF: The STEP-HFpEF Program
|
Oct 14, 2024 |
|
The Effect of Semaglutide on Mortality and COVID-19-Related Deaths - An Analysis From the SELECT Trial
|
Oct 14, 2024 |
|
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease (FLOW Trial)
|
Oct 14, 2024 |
|
Atrial fibrillation and semaglutide efficacy in obesity-related heart failure with preserved ejection fraction: STEP-HFpEF Program
|
Oct 14, 2024 |
|
Effect of Semaglutide on Cardiac Structure and Function in Patients with Obesity-Related Heart Failure
|
Oct 14, 2024 |
|
JACC - October 22, 2024 Issue Summary
|
Oct 14, 2024 |
|
JACC - The Effect of Teleprehabilitation on Adverse Events After Elective Cardiac Surgery: A Randomized Controlled Trial | EACTS 2024
|
Oct 11, 2024 |
|
International Clinical Practice Guideline Recommendations for Acute Pulmonary Embolism: Harmony, Dissonance, and Silence.
|
Oct 07, 2024 |
|
Urinary Metal Levels and Coronary Artery Calcification: Longitudinal Evidence in the Multi-Ethnic Study of Atherosclerosis
|
Oct 07, 2024 |
|
Heart failure risk assessment using biomarkers in patients with atrial fibrillation: Analysis from COMBINE-AF
|
Oct 07, 2024 |
|
Bivalirudin vs Heparin Anticoagulation in STEMI: Confirmation of the BRIGHT-4 Results
|
Oct 07, 2024 |
|
Minimum National Prevalence of Diagnosed Atrial Fibrillation inferred from California Acute Care Facilities
|
Oct 07, 2024 |
|
JACC - October 15, 2024 Issue Summary
|
Oct 07, 2024 |
|
Part Two: Time to Significant Benefit of Finerenone in Patients With Heart Failure | JACC | HFSA 2024
|
Oct 04, 2024 |
|
Finerenone in Patients With a Recent Worsening Heart Failure Event: The FINEARTS-HF Trial | JACC | HFSA 2024
|
Oct 04, 2024 |
|
ACC/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2024 Appropriate Use Criteria for Multimodality Imaging in Cardiovascular Evaluation of Patients Undergoing Nonemergent, Noncardiac Surgery
|
Sep 30, 2024 |
|
Contemporary Training in American Critical Care Cardiology: Minnesota Critical Care Cardiology Education Summit
|
Sep 30, 2024 |
|
Risk of Ischemic Stroke After Patent Foramen Ovale Closure
|
Sep 30, 2024 |
|
Arrhythmic Risk Stratification by Cardiovascular Magnetic Resonance Imaging in Patients with Non-ischemic Cardiomyopathy
|
Sep 30, 2024 |
|
Influence of subclinical atherosclerosis burden and progression on mortality
|
Sep 30, 2024 |
|
Prognostic Implications of Clinical- and Imaging Diagnostic Criteria for Myocarditis
|
Sep 30, 2024 |
|
JACC - October 8, 2024 Issue Summary
|
Sep 30, 2024 |
|
Time to Significant Benefit of Finerenone in Patients with Heart Failure | HFSA 2024
|
Sep 28, 2024 |
|
2024 ACC/AHA Key Data Elements and Definitions for Social Determinants of Health in Cardiology
|
Sep 23, 2024 |
|
Implantable Cardioverter Defibrillator and Resynchronization Therapy in Patients with Overt Chronic Kidney Disease: JACC State-of-the-Art Review
|
Sep 23, 2024 |
|
Quantifying triglyceride-rich lipoprotein atherogenicity, associations with inflammation, and implications for risk assessment using non-HDL cholesterol
|
Sep 23, 2024 |
|
Relationship Between Control of Cardiovascular Risk Factors and Chronic Kidney Disease Progression, Cardiovascular Disease Events, and Mortality in Chinese Adults
|
Sep 23, 2024 |
|
Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients with Heart Failure and Hyperkalemia
|
Sep 23, 2024 |
|
Outcomes of Patients Undergoing Surgery for Complete Vascular Rings
|
Sep 23, 2024 |
|
JACC - October 1, 2024 Issue Summary
|
Sep 23, 2024 |
|
Urinary Metal Levels and Coronary Artery Calcification: Longitudinal Evidence in the Multi-Ethnic Study of Atherosclerosis
|
Sep 20, 2024 |
|
Interactions of Sleep Apnea with the Pathophysiology of Cardiovascular Disease, Part 1: JACC State-of-the-Art Review
|
Sep 16, 2024 |
|
2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized With Heart Failure Focused Update: A Report of the American College of Cardiology Solution Set Oversight Committee
|
Sep 16, 2024 |
|
Predicting Long-term Clinical Outcomes of Patients with Recurrent Pericarditis
|
Sep 16, 2024 |
|
Temporal Trends in Takotsubo Syndrome - Results from the International Takotsubo Registry
|
Sep 16, 2024 |
|
Recovery of Left Ventricular Function and Long-term Outcomes in Patients with Takotsubo Syndrome
|
Sep 16, 2024 |
|
Short-term effects of lower air temperature and cold spells on myocardial infarction hospitalizations in Sweden
|
Sep 16, 2024 |
|
JACC - September 24, 2024 Issue Summary
|
Sep 16, 2024 |
|
Genotype Guided Antiplatelet Therapy: JACC Review Topic of the Week
|
Sep 09, 2024 |
|
Prognostic value of plasma IgG N-glycome traits in pulmonary arterial hypertension
|
Sep 09, 2024 |
|
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF
|
Sep 09, 2024 |
|
Effect of Evogliptin on the Progression of Aortic Valvular Calcification
|
Sep 09, 2024 |
|
Adverse Cardiovascular Outcomes in Patients with Obstructive Sleep Apnea and Obesity: Metabolic Surgery versus Usual Care
|
Sep 09, 2024 |
|
JACC - September 17, 2024 Issue Summary
|
Sep 09, 2024 |
|
RESHAPE-HF2 Trial Findings | ESC 2024
|
Sep 06, 2024 |
|
Effect of Screening for Undiagnosed Atrial Fibrillation and on Stroke Prevention | ESC Congress
|
Sep 05, 2024 |
|
Insights from the SEQUOIA-HCM Trial and SEQUOIA-HCM CRM Substudy | ESC 2024
|
Sep 03, 2024 |
|
Insights from the SEQUOIA-HCM Trial and SEQUOIA-HCM CRM Substudy | ESC 2024
|
Sep 03, 2024 |
|
Association of Postnatal Opioid Exposure and 2-year Neurodevelopmental Outcomes in Infants Undergoing Cardiac Surgery
|
Sep 02, 2024 |
|
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome
|
Sep 02, 2024 |
|
Serial Shock Severity Assessment Within Seventy-Two Hours after Diagnosis: A Cardiogenic Shock Working Group Report
|
Sep 02, 2024 |
|
Prediction of Cumulative Exposure to Atherogenic Lipids During Early Adulthood
|
Sep 02, 2024 |
|
JACC - September 10, 2024 Issue Summary
|
Sep 02, 2024 |
|
Serial Shock Severity Assessment: Some Answers. Still Many Questions. | ESC 2024
|
Aug 31, 2024 |
|
Insights from RESHAPE-HF2 Trial | ESC 2024
|
Aug 31, 2024 |
|
A Secondary Analysis of DANFLU-1 Trial - High vs Standard Dose Influenza Vaccine in CKD | ESC 2024
|
Aug 31, 2024 |
|
Updates from the SELECT Trial: Outcomes by Sex | ESC 2024
|
Aug 30, 2024 |
|
Updates from the STEP-HFpEF Trial | ESC 2024
|
Aug 30, 2024 |
|
An Analysis From the SELECT Trial - COVID-19| ESC 2024
|
Aug 30, 2024 |
|
Insights from the FLOW Trial | ESC 2024
|
Aug 30, 2024 |
|
Antithrombotic Strategies for Patients with Peripheral Artery Disease: JACC Scientific Statement
|
Aug 26, 2024 |
|
Continuous Rhythm Monitoring with Implanted Loop Recorders in Children and Adolescents with Brugada Syndrome
|
Aug 26, 2024 |
|
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM
|
Aug 26, 2024 |
|
Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Watchman FLX Left Atrial Appendage Occlusion
|
Aug 26, 2024 |
|
Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI: A 4-way Comparison from AUGUSTUS
|
Aug 26, 2024 |
|
JACC - September 3, 2024 Issue Summary
|
Aug 26, 2024 |
|
Treatment of Transcatheter Aortic Valve Thrombosis: JACC Review Topic of the Week
|
Aug 19, 2024 |
|
Structural Cardiac Interventions in Patients with Heart Failure: JACC Scientific Statement
|
Aug 19, 2024 |
|
Deep Learning-Based Electrocardiogram Analysis Predicts Biventricular Dysfunction and Dilation in Congenital Heart Disease
|
Aug 19, 2024 |
|
Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity Revascularization
|
Aug 19, 2024 |
|
The Off-Treatment Effects of Olpasiran on Lipoprotein(a) Lowering: OCEAN(a)-DOSE Extension Period Results
|
Aug 19, 2024 |
|
Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials
|
Aug 19, 2024 |
|
JACC - August 27, 2024 Issue Summary
|
Aug 19, 2024 |
|
Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions
|
Aug 12, 2024 |
|
Clinical and Analytical Performance of a Novel Point-of-Care High-Sensitivity Cardiac Troponin I Assay
|
Aug 12, 2024 |
|
Clinical Significance of Diffusion-Weighted Brain MRI Lesions After TAVR: Results of a Patient-Level Pooled Analysis
|
Aug 12, 2024 |
|
Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors Versus GLP-1 Receptor Agonists in Type 2 Diabetes
|
Aug 12, 2024 |
|
Prescription Patterns for Sodium Glucose Cotransporter-2 Inhibitors in US Health Systems
|
Aug 12, 2024 |
|
JACC - August 20, 2024 Issue Summary
|
Aug 12, 2024 |
|
Ending trans fat-the first-ever global elimination program for a noncommunicable disease risk factor: JACC International
|
Aug 05, 2024 |
|
Myocardial Strain Measured by Magnetic Resonance Imaging Predicts Cardiovascular Morbidity and Death
|
Aug 05, 2024 |
|
Comparison of Pressure vs Volume Overload Ventricular Wall Stress in Patients with Valvular Heart Disease
|
Aug 05, 2024 |
|
Contemporary Pediatric Heart Transplant Waitlist Mortality
|
Aug 05, 2024 |
|
Real-world 1-Year Results of Tricuspid Edge-to-Edge Repair from the bRIGHT Study
|
Aug 05, 2024 |
|
JACC - August 13, 2024 Issue Summary
|
Aug 05, 2024 |
|
Pericardial Diseases and Best Practices for Pericardiectomy: JACC State-of-the-Art Review
|
Jul 29, 2024 |
|
Liraglutide Improves Myocardial Perfusion and Energetics and Exercise Tolerance in Patients with Type 2 Diabetes
|
Jul 29, 2024 |
|
A Patch Wearable Cardioverter Defibrillator for Patients at Risk of Sudden Cardiac Arrest
|
Jul 29, 2024 |
|
The influence of epicardial resistance on microvascular resistance reserve
|
Jul 29, 2024 |
|
Effect of Time-Varying Exposure to School-Based Health Promotion on Adiposity in Childhood
|
Jul 29, 2024 |
|
JACC - August 6, 2024 Issue Summary
|
Jul 29, 2024 |
|
Treating Depression to Improve Survival in Coronary Heart Disease: What Have We Learned?
|
Jul 22, 2024 |
|
Mortality after Procedural or Spontaneous Myocardial Infarction
|
Jul 22, 2024 |
|
Temperature and Neurologic Outcomes in Neonates Undergoing Cardiac Surgery: A Society of Thoracic Surgeons Study
|
Jul 22, 2024 |
|
Lipidomic Risk Score to Enhance Cardiovascular Risk Stratification for Primary Prevention
|
Jul 22, 2024 |
|
Association of Adverse Clinical Outcomes with Peri-Infarct Ischemia Detected by Stress Cardiac Magnetic Imaging
|
Jul 22, 2024 |
|
JACC - July 30, 2024 Issue Summary
|
Jul 22, 2024 |
|
Sutureless Valves, a "Wireless" Option for Patients with Aortic Valve Disease: JACC State-of-the-Art Review
|
Jul 15, 2024 |
|
OCT-Guided vs Angiography-Guided Coronary Stent Implantation in Complex Lesions: An ILUMIEN IV Substudy
|
Jul 15, 2024 |
|
Apixaban versus Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation: Insights from ARTESiA
|
Jul 15, 2024 |
|
Impact of Anatomical and Viability-guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy
|
Jul 15, 2024 |
|
Effects of Rapid Up-Titration of Neurohormonal Blockade in Patients with Acute Decompensated Heart Failure
|
Jul 15, 2024 |
|
JACC - July 23, 2024 Issue Summary
|
Jul 15, 2024 |
|
The Role of Psychosocial Stress on Cardiovascular disease in Women: JACC-State-of-the-Art-Review
|
Jul 08, 2024 |
|
Percutaneous coronary revascularization strategies after myocardial infarction: a systematic review and network meta-analysis
|
Jul 08, 2024 |
|
Glycemic Control and Coronary Stent Failure in Patients with Type 2 Diabetes Mellitus
|
Jul 08, 2024 |
|
Semaglutide and NYHA Class in Obesity-Related Heart Failure with Preserved Ejection Fraction: the STEP-HFpEF Program
|
Jul 08, 2024 |
|
Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial
|
Jul 08, 2024 |
|
JACC - July 16, 2024 Issue Summary
|
Jul 08, 2024 |
|
Tricuspid Regurgitation in Patients with Heart Failure and Preserved Ejection Fraction: JACC State-of-the-Art Review
|
Jul 01, 2024 |
|
Coronary artery bypass graft failure in women: incidence and clinical implications
|
Jul 01, 2024 |
|
Impact of Lp(a) Level on LDL-Cholesterol or Apolipoprotein B-Related Risk of Coronary Heart Disease
|
Jul 01, 2024 |
|
Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs
|
Jul 01, 2024 |
|
Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients with Diabetic Cardiomyopathy
|
Jul 01, 2024 |
|
JACC - July 9, 2024 Issue Summary
|
Jul 01, 2024 |
|
Transforming Cardiovascular Care with Artificial Intelligence: From Discovery to Practice: JACC State-of-the-Art Review
|
Jun 24, 2024 |
|
Lessons for Cardiovascular Clinical Investigators: the Tumultuous 2500-Year Journey of Physicians Who Ignited Our Fire
|
Jun 24, 2024 |
|
Pulsed Field vs Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation: Recurrent Atrial Arrhythmia Burden
|
Jun 24, 2024 |
|
Prognostic Value of a 6-Minute Walk Test in Patients with Cardiac Transthyretin Amyloidosis
|
Jun 24, 2024 |
|
Semaglutide and NTproBNP in Obesity-Related HFpEF: Insights from STEP-HFpEF Program
|
Jun 24, 2024 |
|
N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention
|
Jun 24, 2024 |
|
Symptoms as a predictor of the placebo-controlled efficacy of PCI in stable coronary artery disease
|
Jun 24, 2024 |
|
JACC - July 2, 2024 Issue Summary
|
Jun 24, 2024 |
|
Addressing the Global Burden of Cardiovascular Disease in Women: JACC State-of-the-Art Review
|
Jun 17, 2024 |
|
Intravenous Iron Repletion for Patients with Heart Failure and Iron Deficiency: JACC State-of-the-Art Review
|
Jun 17, 2024 |
|
Randomized Trial of a Vascular Care Team vs Education for Patients with Peripheral Artery Disease
|
Jun 17, 2024 |
|
Association of Autoimmune Diseases with Coronary Atherosclerosis Severity and Ischemic Events
|
Jun 17, 2024 |
|
Timing of P2Y12-inhibitor Administration in Patients with STEMI Undergoing Primary PCI
|
Jun 17, 2024 |
|
Ten-Year Mortality after ST-Segment Elevation Myocardial Infarction Compared to the General Population
|
Jun 17, 2024 |
|
JACC - June 25, 2024 Issue Summary
|
Jun 17, 2024 |
|
Artificial Intelligence in Cardiovascular Care — Part 2: Applications: JACC Review Topic of the Week
|
Jun 10, 2024 |
|
Artificial Intelligence for Cardiovascular Care — Part 1: Advances : JACC Review Topic of the Week
|
Jun 10, 2024 |
|
2024 ACC/AHA/AACVPR/APMA/ ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
|
Jun 10, 2024 |
|
Geographical Mapping of Gender Disparities in Authorship of Cardiovascular Literature
|
Jun 10, 2024 |
|
Impact of Social Determinants of Health on Predictive Models for Outcomes after Congenital Heart Surgery
|
Jun 10, 2024 |
|
Mineralocorticoid Receptor Antagonists in Patients with Heart Failure and Impaired Renal Function
|
Jun 10, 2024 |
|
SGLT2 Inhibitor Therapy in Patients with Transthyretin Amyloid Cardiomyopathy
|
Jun 10, 2024 |
|
JACC - June 18, 2024 Issue Summary
|
Jun 10, 2024 |
|
Pollution and Cardiovascular Disease, Part 1: Environmentally Not So Friendly:Global Warming, Air Pollution,and Wildfires: JACC Focus Seminar
|
Jun 03, 2024 |
|
Pollution and Cardiovascular Disease, Part 2: Water, Soil, Noise and Light Pollution: JACC Focus Seminar
|
Jun 03, 2024 |
|
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
|
Jun 03, 2024 |
|
Global, and Regional Cardiovascular Mortality Attributable to Non-optimal Temperatures over Time
|
Jun 03, 2024 |
|
Excess Apolipoprotein B and Cardiovascular Risk in Women and Men
|
Jun 03, 2024 |
|
Randomized Trial of Remote Assessment of Patients after an Acute Coronary Syndrome
|
Jun 03, 2024 |
|
Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction
|
Jun 03, 2024 |
|
JACC - June 11, 2024 Issue Summary
|
Jun 03, 2024 |
|
Reperfusion Injury in Patients with Acute Myocardial Infarction: JACC: Scientific Statement
|
May 26, 2024 |
|
Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review
|
May 26, 2024 |
|
Transcatheter Covered Stent Exclusion of Superior Sinus Venosus Defects
|
May 26, 2024 |
|
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI
|
May 26, 2024 |
|
Effects of Sacubitril/Valsartan in Patients with Heart Failure Across the Spectrum of Kidney Risk
|
May 26, 2024 |
|
Coronary Atherosclerotic Plaque Activity and Myocardial Infarction: A vessel-level analysis of the PRE18FFIR study
|
May 26, 2024 |
|
JACC - June 4, 2024 Issue Summary
|
May 26, 2024 |
|
Clinical Risk Assessment Across the Lifespan in Patients with Congenital Heart Disease: JACC Scientific Statement
|
May 20, 2024 |
|
Personalized Intervention Based on Early Detection of Atherosclerosis: JACC State-of-the-Art Review
|
May 20, 2024 |
|
A Technology-Assisted Web Application for Consumer Access to a Non-prescription Statin Medication
|
May 20, 2024 |
|
Prognostic Value of MRR After Primary PCI: a Pooled Analysis of Individual Patient Data
|
May 20, 2024 |
|
Clinical Outcome of Different Microvascular Injury Patterns after STEMI - A Multicenter Cardiac MRI Study
|
May 20, 2024 |
|
Safety and Efficacy of Metabolic Modulation with Ninerafaxstat in Nonobstructive Hypertrophic Cardiomyopathy: Phase 2 Study
|
May 20, 2024 |
|
JACC - May 28, 2024 Issue Summary
|
May 20, 2024 |
|
Targeting the Substrate for Atrial Fibrillation: JACC Review Topic of the Week
|
May 13, 2024 |
|
Managing Implanted Cardiac Electronic Devices in Patients with Severe Tricuspid Regurgitation: JACC State-of-the-Art Review
|
May 13, 2024 |
|
Case Volumes and Outcomes among Early Career Interventional Cardiologists in the United States
|
May 13, 2024 |
|
Dapagliflozin and Days of Full Health Lost in the DAPA-HF Trial
|
May 13, 2024 |
|
Small Left Ventricle is Associated with an Increased Cardiovascular Risk in Patients with Atrial Fibrillation
|
May 13, 2024 |
|
An Inclisiran First Strategy vs Usual Care in Patients with Atherosclerotic Cardiovascular Disease
|
May 13, 2024 |
|
JACC - May 21, 2024 Issue Summary
|
May 13, 2024 |
|
Ventricular Septal Rupture After Myocardial Infarction: JACC Focus Seminar 3/5
|
May 06, 2024 |
|
Long-term Cardiovascular Risk Associated with Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
|
May 06, 2024 |
|
Uniform or Sex-Specific Cardiac Troponin Thresholds to Rule Out Myocardial Infarction at Presentation
|
May 06, 2024 |
|
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Cardiomyopathies
|
May 06, 2024 |
|
Prevalence of Cardiovascular Disease and Risk Factors among National Football League Alumni and Family Members
|
May 06, 2024 |
|
JACC - May 14, 2024 Issue Summary
|
May 06, 2024 |
|
JACC Focus Seminar on Mechanical Complications of Acute Myocardial Infarction
|
Apr 29, 2024 |
|
Mandibular Advancement vs CPAP for Blood Pressure Reduction in Patients with Obstructive Sleep Apnea
|
Apr 29, 2024 |
|
Association of Lipoprotein(a) Levels with Myocardial Infarction in Patients with Low Attenuation Plaque
|
Apr 29, 2024 |
|
Sacubitril/Valsartan-Related Hypotension in Patients with Heart Failure and Preserved or Mildly Reduced Ejection Fraction
|
Apr 29, 2024 |
|
Combined effects of clonal hematopoiesis and degree of carotid stenosis on cardiovascular mortality
|
Apr 29, 2024 |
|
JACC - May 7, 2024 Issue Summary
|
Apr 29, 2024 |
|
Malignant Hypertension – A Systemic Cardiovascular Disease: JACC Review Topic of the Week
|
Apr 22, 2024 |
|
Association of Disrupted Delta Wave Activity During Sleep with Long-Term Cardiovascular Disease and Mortality
|
Apr 22, 2024 |
|
Permanent Pacemaker Implantation and Long-term Outcomes of Patients Undergoing Concomitant Mitral and Tricuspid Valve Surgery
|
Apr 22, 2024 |
|
Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives
|
Apr 22, 2024 |
|
Limb Outcomes with Ticagrelor Plus Aspirin in Patients with Diabetes Mellitus and Atherosclerosis
|
Apr 22, 2024 |
|
JACC - April 30, 2024 Issue Summary
|
Apr 22, 2024 |
|
The Clinical Challenge of Prosthetic Valve Endocarditis: JACC Focus Seminar
|
Apr 08, 2024 |
|
2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction
|
Apr 08, 2024 |
|
Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Adults with Congenital Heart Disease
|
Apr 08, 2024 |
|
Water Conservation Overrides Osmotic Diuresis during SGLT2 Inhibition in Patients with Heart Failure
|
Apr 08, 2024 |
|
Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score
|
Apr 08, 2024 |
|
Variation in Health Status with Invasive vs Conservative Management of Chronic Coronary Disease
|
Apr 08, 2024 |
|
JACC - April 16, 2024 Issue Summary
|
Apr 08, 2024 |
|
Today's Infective Endocarditis: Not What You Learned in Medical School
|
Apr 01, 2024 |
|
Early Outcomes from a Multicenter Transcatheter Self-Expanding Pulmonary Valve Replacement Registry
|
Apr 01, 2024 |
|
Efficacy and Safety of Dapagliflozin in Patients with Acute Heart Failure
|
Apr 01, 2024 |
|
Stratifying Disease Progression in Patients with Cardiac ATTR Amyloidosis
|
Apr 01, 2024 |
|
Transcatheter Myotomy to Reduce Left Ventricular Outflow Obstruction
|
Apr 01, 2024 |
|
JACC - April 9, 2024 Issue Summary
|
Apr 01, 2024 |
|
Fetal Hemodynamics, Early Survival, and Neurodevelopment in Patients with Cyanotic Congenital Heart Disease
|
Mar 25, 2024 |
|
Mortality in a Nationwide Practice-Based Cohort Receiving Paclitaxel-Coated Devices for Lower Limb Peripheral Artery Disease
|
Mar 25, 2024 |
|
Risk of Dementia During Antihypertensive Drug Therapy in the Elderly
|
Mar 25, 2024 |
|
Validation of the ACC Expert Consensus Decision Pathway for Patients with Chest Pain
|
Mar 25, 2024 |
|
JACC - April 2, 2024 Issue Summary
|
Mar 25, 2024 |
|
Genetic Factors Altering Immune Responses in Atrial Fibrillation: JACC Review Topic of the Week
|
Mar 18, 2024 |
|
Frailty and Cognitive Function in Middle-Aged and Older Adults With Congenital Heart Disease
|
Mar 18, 2024 |
|
Coarctation of Aorta With Tricuspid Aortic Valve Is Not Associated With Ascending Aortic Aneurysm
|
Mar 18, 2024 |
|
Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure
|
Mar 18, 2024 |
|
Prevalence and Outcomes of Patients With Discordant High-Gradient Aortic Stenosis
|
Mar 18, 2024 |
|
JACC - March 26, 2024 Issue Summary
|
Mar 18, 2024 |
|
Histological Typing in Patients with Cardiac Amyloidosis: JACC Review Topic of the Week
|
Mar 11, 2024 |
|
Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease
|
Mar 11, 2024 |
|
Kidney Injury After Minimal Radiographic Contrast Administration in Patients with Acute Coronary Syndromes
|
Mar 11, 2024 |
|
Electrophysiological Characterization of Subclinical and Overt Hypertrophic Cardiomyopathy by Magnetic Resonance Imaging-Guided Electrocardiography
|
Mar 11, 2024 |
|
Association of Antiarrhythmic Drug Therapy with Syncope and Pacemaker Implantation in Patients with Atrial Fibrillation
|
Mar 11, 2024 |
|
JACC - March 19, 2024 Issue Summary
|
Mar 11, 2024 |
|
JACC - March 12, 2024 Issue Summary: Dr. Valentin Fuster's Top Picks for 2023
|
Mar 04, 2024 |
|
Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure: JACC State-of-the-Art Review
|
Feb 26, 2024 |
|
Intraoperative Anemia Mediates Sex Disparity in Operative Mortality After Coronary Artery Bypass Grafting
|
Feb 26, 2024 |
|
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI
|
Feb 26, 2024 |
|
Surveillance Stress Testing After Percutaneous Intervention for Patients With Multivessel or Left Main Coronary Disease
|
Feb 26, 2024 |
|
Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease
|
Feb 26, 2024 |
|
JACC - March 5, 2024 Issue Summary
|
Feb 26, 2024 |
|
"Food Is Medicine" Strategies for Nutrition Security and Cardiometabolic Health Equity: JACC State-of-the-Art Review
|
Feb 19, 2024 |
|
Mortality After Major Cardiovascular Events in Survivors of Childhood Cancer
|
Feb 19, 2024 |
|
Infective Endocarditis in Patients Addicted to Injected Opioid Drugs
|
Feb 19, 2024 |
|
Phenotypic Expression and Clinical Outcomes in Patients with Arrhythmogenic Cardiomyopathies
|
Feb 19, 2024 |
|
" Sex Differences in Association of Physical Activity With All-Cause and Cardiovascular Mortality"
|
Feb 19, 2024 |
|
JACC - February 27, 2024 Issue Summary
|
Feb 19, 2024 |
|
Participation In Competitive Sports By Patients With Congenital Heart Disease: Aha/Acc And Eapc/Esc/Aepc Guidelines Comparison
|
Feb 12, 2024 |
|
Vascular Regenerative Cell Deficiencies In South Asian Adults
|
Feb 12, 2024 |
|
Increased Risk of Myocardial Infarction, Heart Failure And Atrial Fibrillation After Spinal Cord Injury
|
Feb 12, 2024 |
|
Intrahepatic Transcriptomics Differentiate Advanced Fibrosis And Clinical Outcomes In Adults With Fontan Circulation
|
Feb 12, 2024 |
|
Effect of a Salt Substitute on Incidence of Hypertension and Hypotension Among Normotensive Adults
|
Feb 12, 2024 |
|
JACC - February 20, 2024 Issue Summary
|
Feb 12, 2024 |
|
Measuring Coronary Blood Flow And Microvascular Resistance By Thermodilution: JACC Review Topic of the Week
|
Feb 05, 2024 |
|
Implantable Hemodynamic Monitors Improve Survival In Patients With Heart Failure And Reduced Ejection Fraction
|
Feb 05, 2024 |
|
Bleeding Outcomes In Patients Treated With Asundexian In Phase Ii Trials
|
Feb 05, 2024 |
|
Long-Term Efficacy of Evolocumab In Patients With Or Without Multivessel Coronary Disease
|
Feb 05, 2024 |
|
Randomized Trial of Effect of Bariatric Surgery On Blood Pressure After Five Years
|
Feb 05, 2024 |
|
JACC - February 13, 2024 Issue Summary
|
Feb 05, 2024 |
|
Clinical Presentation, Classification, And Outcomes of Cardiogenic Shock In Children
|
Jan 29, 2024 |
|
Large-Scale Proteomics Identifies Novel Biomarkers And Circulating Risk Factors For Aortic Stenosis
|
Jan 29, 2024 |
|
Universal Risk Prediction For Individuals With And Without Atherosclerotic Cardiovascular Disease
|
Jan 29, 2024 |
|
Outcomes According To Coronary Revascularization Modality In the Ischemia Trial
|
Jan 29, 2024 |
|
JACC - February 6, 2024 Issue Summary
|
Jan 29, 2024 |
|
Racial And Ethnic Disparities In Perioperative Health Care Among Patients Undergoing Cardiac Surgery: JACC State-of-the-Art Review
|
Jan 22, 2024 |
|
Growth of the Neo-Aortic Root And Prognosis of Transposition of the Great Arteries
|
Jan 22, 2024 |
|
Prognostic Implications of Initial Focal Contrast Enhancement In Acute Type B Intramural Hematoma
|
Jan 22, 2024 |
|
Transcatheter Edge-To-Edge Repair In Coapt-Ineligible Patients With Functional Mitral Regurgitation
|
Jan 22, 2024 |
|
Randomized Trial of Macitentan/Tadalafil Combination Therapy For Pulmonary Artery Hypertension
|
Jan 22, 2024 |
|
JACC - January 30, 2024 Issue Summary
|
Jan 22, 2024 |
|
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review
|
Jan 15, 2024 |
|
Anxiety And Depression Symptoms In An International Study of Adults With Congenital Heart Disease
|
Jan 15, 2024 |
|
Risk of Death In Patients With Coronary Artery Disease Taking Nitrates And Phosphodiesterase-5-Inhibitors
|
Jan 15, 2024 |
|
Guiding Intervention For Complex Coronary Lesions By Optical Coherence Tomography Or Intravascular Ultrasound
|
Jan 15, 2024 |
|
Lipoprotein(A) is Markedly More Atherogenic Than Ldl: An Apolipoprotein B-Based Genetic Analysis
|
Jan 15, 2024 |
|
JACC - January 23, 2024 Issue Summary
|
Jan 15, 2024 |
|
Sudden Cardiac Death In Young Athletes: Jacc State-Of-The-Art Review
|
Jan 08, 2024 |
|
Comparison of Direct Oral Anticoagulants Vs Vitamin-K Antagonists After Transcatheter Mitral Valve Replacement
|
Jan 08, 2024 |
|
Cardiac Reoperation Or Transcatheter Mitral Valve Replacement For Patients With Failed Mitral Prostheses
|
Jan 08, 2024 |
|
Sex-Specific Prognosis of Left Ventricular Size And Function Following Repair of Degenerative Mitral Regurgitation
|
Jan 08, 2024 |
|
Rethinking False Positive Exercise Electrocardiographic Stress Tests By Assessing Coronary Microvascular Function
|
Jan 08, 2024 |
|
JACC - January 16, 2024 Issue Summary
|
Jan 08, 2024 |
|
2023 Acc/Aha/Accp/Hrs Guideline For the Diagnosis And Management of Atrial Fibrillation
|
Jan 02, 2024 |
|
Antithrombotic Therapy For Patients Undergoing Cardiac Electrophysiological And Interventional Procedures: Jacc State-Of-The-Art Review
|
Jan 02, 2024 |
|
Lung-To-Heart Nano-In-Micro Peptide Promotes Cardiac Recovery In a Pig Model of Chronic Heart Failure
|
Jan 02, 2024 |
|
Contemporary Management And Outcomes of Patients With High-Risk Pulmonary Embolism
|
Jan 02, 2024 |
|
Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After Pci: Stopdapt-2 5-Year Results
|
Jan 02, 2024 |
|
Health Status After Transcatheter Tricuspid-Valve Repair In Patients With Severe Tricuspid Regurgitation: Triluminate Pivotal Trial
|
Jan 02, 2024 |
|
JACC - January 2 - 9, 2024 Issue Summary
|
Jan 02, 2024 |
|
JACC - December 19 - 26, 2023 Issue Summary: A Heart-Healthy and Stroke-Free World: Using Data to Inform Global Action
|
Dec 11, 2023 |
|
Disparities in Diagnosis, Treatment, and Outcomes of Peripheral Artery Disease: JACC Scientific Statement
|
Dec 04, 2023 |
|
Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease
|
Dec 04, 2023 |
|
Association of Lipoprotein(a) Levels with Myocardial Fibrosis in the Multi-Ethnic Study of Atherosclerosis
|
Dec 04, 2023 |
|
Lipoprotein(a) and Risks of Peripheral Artery Disease, Abdominal Aortic Aneurysm, and Major Adverse Limb Events
|
Dec 04, 2023 |
|
Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in Seven Clinical Trials
|
Dec 04, 2023 |
|
JACC - December 12, 2023 Issue Summary
|
Dec 04, 2023 |
|
Comparison of Intravascular Imaging, Functional or Angiographically Guided Coronary Intervention
|
Nov 27, 2023 |
|
Neuroimaging and neurodevelopmental outcomes among individuals with complex congenital heart disease
|
Nov 27, 2023 |
|
Adjusting for Congenital Heart Surgery Risk Using Administrative Data
|
Nov 27, 2023 |
|
Systemic Atrioventricular Valve Surgery in Patients with Congenitally Corrected Transposition of the Great Vessels
|
Nov 27, 2023 |
|
Longitudinal Changes in Pulmonary Pressure in Late Life: The Atherosclerosis Risk in Communities (ARIC) Study
|
Nov 27, 2023 |
|
JACC - December 5, 2023 Issue Summary
|
Nov 27, 2023 |
|
Novel Imaging Approaches to Cardiac Manifestations of Systemic Inflammatory Diseases: JACC Scientific Statement
|
Nov 20, 2023 |
|
Can Machine Learning Aid the Selection of Percutaneous vs. Surgical Revascularisation?
|
Nov 20, 2023 |
|
The Mortality Burden of Untreated Aortic Stenosis
|
Nov 20, 2023 |
|
Semaglutide Effects According to Ejection Fraction in Heart Failure with Preserved Ejection Fraction and Obesity
|
Nov 20, 2023 |
|
Primary Prevention of Subclinical Atherosclerosis In Young Adults: Jacc Review Topic of the Week
|
Nov 20, 2023 |
|
Determinants of Progression And Regression of Subclinical Atherosclerosis Over Six Years
|
Nov 20, 2023 |
|
JACC - November 28, 2023 Issue Summary
|
Nov 20, 2023 |
|
Management of Adults with Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review
|
Nov 13, 2023 |
|
Long-Term Outcomes of Invasive vs Conservative Strategies for Older Patients with Non-ST-Elevation Acute Coronary Syndromes
|
Nov 13, 2023 |
|
Risk of Type B Dissection in Marfan Syndrome: The Cornell Aortic Aneurysm Registry
|
Nov 13, 2023 |
|
Sleep-Related Hypoxia, Right Ventricular Dysfunction and Survival in Group 1 Pulmonary Arterial Hypertension: PVDOMICS Study
|
Nov 13, 2023 |
|
Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation
|
Nov 13, 2023 |
|
JACC - November 21, 2023 Issue Summary
|
Nov 13, 2023 |
|
Deep Learning-Enabled Assessment of Left Heart Structure and Function Predicts Cardiovascular Outcomes
|
Nov 06, 2023 |
|
Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease
|
Nov 06, 2023 |
|
Multi-omics analysis provides novel pathways related to progression of heart failure
|
Nov 06, 2023 |
|
Association of Age and Sex with Use of Transcatheter Aortic Valve Replacement in France
|
Nov 06, 2023 |
|
JACC - November 14, 2023 Issue Summary
|
Nov 06, 2023 |
|
Implementation of Global Hearts Hypertension Control Programs in 32 Low- and Middle-Income Countries: JACC International
|
Oct 30, 2023 |
|
Dapagliflozin in Patients With Heart Failure and Deterioration in Renal Function
|
Oct 30, 2023 |
|
Efficacy of Sotagliflozin in Adults with Type 2 Diabetes In Relation to Baseline Hemoglobin A1c
|
Oct 30, 2023 |
|
Stress Perfusion Cardiac Magnetic Resonance vs SPECT Imaging for Detection of Coronary Artery Disease
|
Oct 30, 2023 |
|
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications
|
Oct 30, 2023 |
|
JACC - November 7, 2023 Issue Summary
|
Oct 30, 2023 |
|
Cardiovascular Fellowship Training in Cardio-Obstetrics: JACC Review Topic of the Week
|
Oct 23, 2023 |
|
Public Out-of-hospital Cardiac Arrests in Residential Neighborhoods
|
Oct 23, 2023 |
|
Network Meta-analysis of Initial Antithrombotic Regimens after Left Atrial Appendage Occlusion
|
Oct 23, 2023 |
|
Patients With Hypertrophic Cardiomyopathy and Normal Genetic Investigations Have Few Affected Relatives
|
Oct 23, 2023 |
|
Concomitant Coronary Atheroma Regression and Stabilization in Response to Lipid-Lowering Therapy
|
Oct 23, 2023 |
|
JACC - October 31, 2023 Issue Summary
|
Oct 23, 2023 |
|
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
|
Oct 16, 2023 |
|
Risk-Stratification for Hospital Mortality and Postoperative Complications in Patients with Shock undergoing Cardiac Surgery
|
Oct 16, 2023 |
|
Coronary Fractional Flow Reserve Assessment by Computerized Tomography in Patients with Type 2 Myocardial Infarction
|
Oct 16, 2023 |
|
Impact of Positron Emission Tomographic Myocardial Perfusion Imaging on Patient Selection for Revascularization
|
Oct 16, 2023 |
|
Psychosocial Characteristics of Women Presenting with Myocardial Infarction With or Without Obstructive Coronary Arteries
|
Oct 16, 2023 |
|
JACC - October 24, 2023 Issue Summary
|
Oct 16, 2023 |
|
International Consensus on Differential Diagnosis and Management of Patients with Danon Disease: JACC State-of-the-Art Review
|
Oct 09, 2023 |
|
Magnetic Resonance Spectroscopy of Brain Metabolism in Fetuses with Congenital Heart Disease
|
Oct 09, 2023 |
|
Flurpiridaz F-18 PET Myocardial Perfusion Imaging in Patients with Suspected Coronary Artery Disease
|
Oct 09, 2023 |
|
10-year Cardiovascular Risk in Patients with Newly-Diagnosed Type 2 Diabetes Mellitus
|
Oct 09, 2023 |
|
Comparison of Antiplatelet Monotherapies after Percutaneous Coronary Intervention According to Clinical, Ischemic, and Bleeding Risks
|
Oct 09, 2023 |
|
JACC - October 17, 2023 Issue Summary
|
Oct 09, 2023 |
|
Childhood Screening for Familial Hypercholesterolemia: JACC Review Topic of the Week
|
Oct 02, 2023 |
|
Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke: JACC State-of-the-Art Review
|
Oct 02, 2023 |
|
Prognostic Implications of the Extent of Cardiac Damage in Patients with Fabry Disease
|
Oct 02, 2023 |
|
Outcomes of Heart Transplant Donation after Circulatory Death
|
Oct 02, 2023 |
|
Performance of the ACC/AHA Pooled Cohort Cardiovascular Risk Equations in Clinical Practice
|
Oct 02, 2023 |
|
Relationship of Daily Step Counts to All-Cause Mortality and Cardiovascular Events
|
Oct 02, 2023 |
|
JACC - October 10, 2023 Issue Summary
|
Oct 02, 2023 |
|
Durable Mechanical Circulatory Support: JACC Scientific Statement
|
Sep 25, 2023 |
|
Outcomes after Hybrid Palliation for Infants with Critical Left Heart Obstruction
|
Sep 25, 2023 |
|
Genetic Insights on the Relation of Vascular Risk Factors and Cervical Artery Dissection
|
Sep 25, 2023 |
|
Validation of Risk-Stratification for Cardiac Events in Pregnant Women with Valvular Heart Disease
|
Sep 25, 2023 |
|
LDL-C reduction with lipid-lowering therapy for primary prevention of major vascular events among older individuals
|
Sep 25, 2023 |
|
JACC - October 3, 2023 Issue Summary
|
Sep 25, 2023 |
|
Clinical Pathway for Coronary Atherosclerosis in Patients without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review
|
Sep 18, 2023 |
|
Chronic Medication Burden after Cardiac Surgery for Pediatric Medicaid Beneficiaries
|
Sep 18, 2023 |
|
Impaired Renal Function and Major Cardiovascular Events in Young Adults
|
Sep 18, 2023 |
|
Association of High-Sensitivity Cardiac Troponin-T with 30-day and Five-year Mortality after Cardiac Surgery
|
Sep 18, 2023 |
|
Transcatheter Edge-to-Edge Repair in 5,000 Patients with Secondary Mitral Regurgitation: COAPT Post-Approval Study
|
Sep 18, 2023 |
|
JACC - September 26, 2023 Issue Summary
|
Sep 18, 2023 |
|
Comprehensive Management of Anoca, Part 2—Program Development, Treatment, And Research Initiatives: Jacc State-Of-The-Art Review
|
Sep 11, 2023 |
|
Comprehensive Management of ANOCA Part 1 – Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review
|
Sep 11, 2023 |
|
Survival after Cardiac Transplantation in Adults with Single-Ventricle Congenital Heart Disease
|
Sep 11, 2023 |
|
20-Year Experience with Repair of Pulmonary Atresia or Stenosis and Major Aortopulmonary Collateral Arteries
|
Sep 11, 2023 |
|
Association of Coronary Artery Calcium Detected by Routine Ungated CT Imaging with Cardiovascular Outcomes
|
Sep 11, 2023 |
|
Impact of Complete Revascularization in the ISCHEMIA Trial
|
Sep 11, 2023 |
|
JACC - September 19, 2023 Issue Summary
|
Sep 11, 2023 |
|
Ventricular Arrhythmias in Adults with Congenital Heart Disease Part I: JACC State-of-the-Art Review
|
Sep 04, 2023 |
|
Vasovagal Responses to Human Monomorphic Ventricular Tachycardia: Hemodynamic Implications From Sinus Rate Analysis
|
Sep 04, 2023 |
|
Underutilization of Mineralocorticoid Antagonists in Patients with Heart Failure and Reduced Ejection Fraction
|
Sep 04, 2023 |
|
Cardiovascular Events after Aortic Root Repair in Patients with Marfan Syndrome
|
Sep 04, 2023 |
|
Long-term Outcome and Prognosis of Non-Infectious Thoracic Aortitis
|
Sep 04, 2023 |
|
JACC - September 12, 2023 Issue Summary
|
Sep 04, 2023 |
|
Ablation To Reduce Atrial Fibrillation Burden And Improve Outcomes: Jacc Review Topic of the Week
|
Aug 28, 2023 |
|
Efficacy of Dapagliflozin According To Geographical Location of Patients With Heart Failure
|
Aug 28, 2023 |
|
Trends in Mortality Following ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: 2003-2018
|
Aug 28, 2023 |
|
Long-term Outcomes of Cardiogenic Shock Complicating Myocardial Infarction
|
Aug 28, 2023 |
|
Temporal trends in non-cardiovascular morbidity and mortality following acute myocardial infarction: A nationwide Danish study
|
Aug 28, 2023 |
|
JACC - September 5, 2023 Issue Summary
|
Aug 28, 2023 |
|
Neighborhood Childhood Opportunity, Race/Ethnicity, and Surgical Outcomes in Children with Congenital Heart Disease
|
Aug 21, 2023 |
|
Age-Tailored Monitoring of Myocardial Involvement in Arrhythmogenic Cardiomyopathy
|
Aug 21, 2023 |
|
Predictors of Mortality with a Fully Magnetically Levitated LVAD at 5-years: A MOMENTUM-3 Trial Analysis
|
Aug 21, 2023 |
|
Prevalence, Characteristics and Prognostic Relevance of Donor-Transmitted Coronary Artery Disease in Heart Transplant Recipients
|
Aug 21, 2023 |
|
JACC - August 29, 2023 Issue Summary
|
Aug 21, 2023 |
|
ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases. JACC Guideline Comparison
|
Aug 14, 2023 |
|
Risk of Arrhythmic Death in Patients with Non-Ischemic Cardiomyopathy: JACC Review Topic of the Week
|
Aug 14, 2023 |
|
Right Atrial Adaptation to Precapillary Pulmonary Hypertension: Pressure-Volume, Cardiomyocyte and Histological Analysis
|
Aug 14, 2023 |
|
Bleeding and Ischemic Risks of Ticagrelor Monotherapy after Coronary Interventions
|
Aug 14, 2023 |
|
Cardiac Effects of Long Duration Space Flight
|
Aug 14, 2023 |
|
Return-to-Play for Elite Athletes with Genetic Heart Diseases Predisposing to Sudden Cardiac Death
|
Aug 14, 2023 |
|
JACC - August 22, 2023 Issue Summary
|
Aug 14, 2023 |
|
Transformative Impact of Geroscience On Understanding Cvd In Older Adults And Developing New Therapeutic Strategies
|
Aug 07, 2023 |
|
Low Dose Colchicine (0.5 mg daily) for the Secondary Prevention of Coronary Artery Disease
|
Aug 07, 2023 |
|
Pulmonary Artery Hypoplasia in Neonates with Tetralogy of Fallot
|
Aug 07, 2023 |
|
Fatal Cardiac Arrhythmias During Electronic Gaming In Patients With Genetically Mediated Heart Diseases
|
Aug 07, 2023 |
|
Subcutaneous Implantable Cardioverter Defibrillators in Patients with Congenital Heart Disease
|
Aug 07, 2023 |
|
First-in-Human Transapical Beating-Heart Septal Myectomy in Patients with Hypertrophic Obstructive Cardiomyopathy
|
Aug 07, 2023 |
|
JACC - August 15, 2023 Issue Summary
|
Aug 07, 2023 |
|
Bridging Treatment Implementation Gaps In Patients With Heart Failure: Jacc Focus Seminar
|
Jul 31, 2023 |
|
Management of Worsening Heart Failure With Reduced Ejection Fraction: Jacc Review Topic of the Week
|
Jul 31, 2023 |
|
Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Review Topic of the Week
|
Jul 31, 2023 |
|
GLP1 Receptor Agonist Therapy with and without SGLT2 inhibitors in Patients with Type 2 Diabetes
|
Jul 31, 2023 |
|
Prognostic Performance of Right Ventricular Global Longitudinal Strain Measurements in Patients with Ebstein Anomaly
|
Jul 31, 2023 |
|
Right Ventricular Function and Coupling to Pulmonary Circulation in Heart Failure with Preserved Ejection Fraction
|
Jul 31, 2023 |
|
High-Sensitivity Cardiac Troponin for Risk Assessment in Patients with Chronic Coronary Artery Disease
|
Jul 31, 2023 |
|
JACC - August 8, 2023 Issue Summary
|
Jul 31, 2023 |
|
Mechanisms of Aortic Dilation in Patients with Bicuspid Aortic Valve: JACC: State-of-the-Art Review
|
Jul 24, 2023 |
|
Global Comparison of Re-admission Rates for Patients with Heart Failure
|
Jul 24, 2023 |
|
C-Reactive Protein and Risk of Incident Heart Failure in Patients with Cardiovascular Disease
|
Jul 24, 2023 |
|
Combination lipid-lowering therapy in patients treated with percutaneous coronary intervention in practice: assessing RACING generalizability
|
Jul 24, 2023 |
|
Post-approval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System
|
Jul 24, 2023 |
|
JACC - August 1, 2023 Issue Summary
|
Jul 24, 2023 |
|
Omega-3 Fatty Acid Biomarkers and Incident Atrial Fibrillation
|
Jul 17, 2023 |
|
Role of Human Epicardial Adipose Tissue-Derived miR-92a-3p in Myocardial Redox State
|
Jul 17, 2023 |
|
Complete Revascularization and Angina-Related Health Status in the ISCHEMIA Trial
|
Jul 17, 2023 |
|
Short-term Outcomes of Tricuspid Edge-to-Edge Repair in Clinical Practice
|
Jul 17, 2023 |
|
JACC - July 25, 2023 Issue Summary
|
Jul 17, 2023 |
|
JACC - July 18, 2023 Issue Summary
|
Jul 10, 2023 |